Literature DB >> 9227340

The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.

P Viacava1, A G Naccarato, P Collecchi, S Ménard, V Castronovo, G Bevilacqua.   

Abstract

Laminin is a glycoprotein of the basement membrane (BM), involved in a variety of normal and pathological cellular events including tumour invasion and metastasis. Cells bind laminin through different types of receptor. The 67-kD laminin receptor (67LR) is a cell-surface protein which binds laminin with high affinity. 67LR expression has been shown to increase in neoplastic cells, compared with normal tissues, and 67LR seems to play an important role during the first steps of neoplastic progression. In this study, 67LR expression was analysed during the morphological phases of breast cancer progression from normal tissue to invasive carcinoma. A total of 506 formalin-fixed, paraffin-embedded normal breast structures and lesions were stained by immunohistochemistry usign the MLuC5 monoclonal antibody, which is specific for 67LR. The results show that in normal breast and in any kind of breast lesion, myoepithelial and endothelial cells express 67LR. While 67LR is not seen in the epithelium of normal breast, cysts, adenosis, and benign tumours, it is expressed in the epithelial cells of several hyperplasias and carcinomas in situ, both ductal and lobular, as well as in all invasive carcinomas. The 67LR-positive cell subpopulation expands from hyperplastic lesions to invasive carcinoma, suggesting that 67LR could be related to the induction and progression of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227340     DOI: 10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  11 in total

Review 1.  Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein.

Authors:  Vincent DiGiacomo; Daniel Meruelo
Journal:  Biol Rev Camb Philos Soc       Date:  2015-01-28

2.  The Transition of the 37-Kda Laminin Receptor (Rpsa) to Higher Molecular Weight Species: Sumoylation or Artifact?

Authors:  Vincent Digiacomo; Ivan A Gando; Lisa Venticinque; Alicia Hurtado; Daniel Meruelo
Journal:  Cell Mol Biol Lett       Date:  2015-12       Impact factor: 5.787

3.  67-kDa laminin receptor-dependent protein phosphatase 2A (PP2A) activation elicits melanoma-specific antitumor activity overcoming drug resistance.

Authors:  Shuntaro Tsukamoto; Yuhui Huang; Daisuke Umeda; Shuhei Yamada; Shuya Yamashita; Motofumi Kumazoe; Yoonhee Kim; Motoki Murata; Koji Yamada; Hirofumi Tachibana
Journal:  J Biol Chem       Date:  2014-10-07       Impact factor: 5.157

Review 4.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

5.  67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis.

Authors:  Motofumi Kumazoe; Kaori Sugihara; Shuntaro Tsukamoto; Yuhui Huang; Yukari Tsurudome; Takashi Suzuki; Yumi Suemasu; Naoki Ueda; Shuya Yamashita; Yoonhee Kim; Koji Yamada; Hirofumi Tachibana
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

6.  Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor.

Authors:  Christine P Diggle; Sheena Cruickshank; Jonathon D Olsburgh; Stephanie Pellegrin; Barbara Smith; Rosamonde E Banks; Peter J Selby; Margaret A Knowles; Jennifer Southgate; Patricia Harnden
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow.

Authors:  J Kitayama; H Nagawa; N Tsuno; T Osada; K Hatano; E Sunami; H Saito; T Muto
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

Review 8.  Molecular drivers of lobular carcinoma in situ.

Authors:  Greg J Logan; David J Dabbs; Peter C Lucas; Rachel C Jankowitz; Daniel D Brown; Beth Z Clark; Steffi Oesterreich; Priscilla F McAuliffe
Journal:  Breast Cancer Res       Date:  2015-06-04       Impact factor: 6.466

9.  Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis.

Authors:  W Ketchart; K M Smith; T Krupka; B M Wittmann; Y Hu; P A Rayman; Y Q Doughman; J M Albert; X Bai; J H Finke; Y Xu; A A Exner; M M Montano
Journal:  Oncogene       Date:  2012-09-10       Impact factor: 9.867

10.  Changes in the in vitro activity of platinum drugs when administered in two aliquots.

Authors:  Zaynab Al-Eisawi; Philip Beale; Charles Chan; Jun Qing Yu; Nicholas Proschogo; Mark Molloy; Fazlul Huq
Journal:  BMC Cancer       Date:  2016-08-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.